- Home
- CELU vs CNF Comparison
CELU vs CNF Comparison
Compare CELU & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- CNF
- Stock Information
- Founded
- CELU 2016
- CNF 1999
- Country
- CELU United States
- CNF China
- Employees
- CELU N/A
- CNF N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- CNF Finance: Consumer Services
- Sector
- CELU Health Care
- CNF Finance
- Exchange
- CELU Nasdaq
- CNF Nasdaq
- Market Cap
- CELU 50.4M
- CNF 59.0M
- IPO Year
- CELU N/A
- CNF 2018
- Fundamental
- Price
- CELU $1.68
- CNF $1.12
- Analyst Decision
- CELU
- CNF
- Analyst Count
- CELU 0
- CNF 0
- Target Price
- CELU N/A
- CNF N/A
- AVG Volume (30 Days)
- CELU 182.6K
- CNF 22.5K
- Earning Date
- CELU 12-06-2024
- CNF 03-27-2025
- Dividend Yield
- CELU N/A
- CNF N/A
- EPS Growth
- CELU N/A
- CNF N/A
- EPS
- CELU N/A
- CNF 0.24
- Revenue
- CELU $48,200,000.00
- CNF $109,788,152.00
- Revenue This Year
- CELU N/A
- CNF N/A
- Revenue Next Year
- CELU $233.89
- CNF $13.09
- P/E Ratio
- CELU N/A
- CNF $4.67
- Revenue Growth
- CELU 225.94
- CNF 12.99
- 52 Week Low
- CELU $1.30
- CNF $0.81
- 52 Week High
- CELU $7.97
- CNF $2.84
- Technical
- Relative Strength Index (RSI)
- CELU 37.21
- CNF 47.25
- Support Level
- CELU $1.85
- CNF $1.07
- Resistance Level
- CELU $2.18
- CNF $1.23
- Average True Range (ATR)
- CELU 0.26
- CNF 0.09
- MACD
- CELU -0.05
- CNF -0.02
- Stochastic Oscillator
- CELU 5.46
- CNF 20.87
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.
About CNF CNFinance Holdings Limited each representing twenty (20)
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, it has an operation in PRC.